首页> 外文OA文献 >Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study.

【2h】

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study.

机译：L-天冬酰胺酶与甲氨蝶呤和地塞米松（aspametDex方案）在难治性或复发性结外NK / T细胞淋巴瘤患者中的疗效，II期研究。

页面导航

摘要
著录项
相似文献
相关主题

摘要

International audience

机译：国际观众

著录项

作者
Jaccard Arnaud; Gachard Nathalie; Marin Benoît; Rogez Sylvie; Audrain Marie; Suarez Felipe; Tilly Hervé; Morschhauser Franck; Thieblemont Catherine; Ysebaert Loic; Devidas Alain; Petit Barbara; De Leval Laurence; Gaulard Philippe; Feuillard Jean; Bordessoule Dominique; Hermine Olivier;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. [J] . Jaccard A, Gachard N, Marin B, Blood: The Journal of the American Society of Hematology . 2011,第6期

机译：L-天冬酰胺酶联合氨甲蝶呤和地塞米松（AspaMetDex方案）对难治性或复发性结外NK / T细胞淋巴瘤患者的疗效，一项2期研究。
2. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. [J] . Yamaguchi M, Suzuki R, Kwong YL, Cancer science. . 2008,第5期

机译：地塞米松，甲氨蝶呤，异环磷酰胺，L-天冬酰胺酶和依托泊苷（SMILE）化疗用于晚期，复发性或难治性结外自然杀手（NK）/ T细胞淋巴瘤和白血病的I期研究。
3. Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. [J] . Yamaguchi M, Kwong YL, Kim WS, Journal of Clinical Oncology . 2011,第33期

机译：针对新诊断的IV期，复发性或难治性结外自然杀手（NK）/ T细胞淋巴瘤，鼻型的SMILE化疗的II期研究：NK细胞肿瘤研究组研究。
4. THALIDOMIDE PLUS INTERMEDIATE-DOSE DEXAMETHASONE IN REFRACTORY/RELAPSED AL PATIENTS [C] . Giovanni Palladini, Vittorio PerfettF, Stefano Perlini, International Symposium on Amyloidosis . 2005

机译：沙利度胺加上难治性/复发患者中的中间剂量地塞米松
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Efficacy of combined gemcitabine oxaliplatin and pegaspargase (P-gemox regimen) in patients with newly diagnosed advanced-stage or relapsed/refractory extranodal NK/T-cell lymphoma [O] . Jing-hua Wang, Liang Wang, Cheng-cheng Liu, 2016

机译：吉西他滨奥沙利铂和培加斯加酶联合治疗（P-gemox方案）对新诊断的晚期或复发/难治性结外NK / T细胞淋巴瘤患者的疗效
7. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study. [O] . Jaccard Arnaud, Gachard Nathalie, Marin Benoît, 2010

机译：II期研究显示，L-天冬酰胺酶联合氨甲蝶呤和地塞米松（AspaMetDex方案）对难治性或复发性结外NK / T细胞淋巴瘤患者的疗效。

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase II study.

摘要

著录项

相似文献

相关主题

期刊订阅